These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31948661)

  • 1. Insulin Resistance Modifies the Effects of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction (from the OMEGA-REMODEL Randomized Clinical Trial).
    Fujikura K; Heydari B; Ge Y; Kaneko K; Abdullah S; Harris WS; Jerosch-Herold M; Kwong RY
    Am J Cardiol; 2020 Mar; 125(5):678-684. PubMed ID: 31948661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.
    Kwong RY; Heydari B; Ge Y; Abdullah S; Fujikura K; Kaneko K; Harris WS; Jerosch-Herold M; Antman EM; Seidman JG; Pfeffer MA
    PLoS One; 2019; 14(9):e0222061. PubMed ID: 31532795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
    Heydari B; Abdullah S; Pottala JV; Shah R; Abbasi S; Mandry D; Francis SA; Lumish H; Ghoshhajra BB; Hoffmann U; Appelbaum E; Feng JH; Blankstein R; Steigner M; McConnell JP; Harris W; Antman EM; Jerosch-Herold M; Kwong RY
    Circulation; 2016 Aug; 134(5):378-91. PubMed ID: 27482002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial.
    Bernhard B; Heydari B; Abdullah S; Francis SA; Lumish H; Wang W; Jerosch-Herold M; Harris WS; Kwong RY
    Int J Cardiol; 2024 Mar; 399():131698. PubMed ID: 38184150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ω-3 Fatty Acids Ethyl Esters Suppress Cerebral Vasospasm and Improve Clinical Outcome Following Aneurysmal Subarachnoid Hemorrhage.
    Nakagawa I; Yokoyama S; Omoto K; Takeshima Y; Matsuda R; Nishimura F; Yamada S; Yokota H; Motoyama Y; Park YS; Nakase H
    World Neurosurg; 2017 Mar; 99():457-464. PubMed ID: 27993744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial.
    Duengen HD; Kim RJ; Zahger D; Orvin K; Kornowski R; Admon D; Kettner J; Shimony A; Otto C; Becka M; Kanefendt F; Romo AI; Hasin T; Ostadal P; Rojas GC; Senni M;
    Am Heart J; 2020 Jun; 224():129-137. PubMed ID: 32375104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients: a Randomized Placebo-Controlled Trial.
    Gharekhani A; Dashti-Khavidaki S; Lessan-Pezeshki M; Khatami MR
    Iran J Kidney Dis; 2016 Sep; 10(5):310-318. PubMed ID: 27721230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
    Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
    Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
    Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM
    Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does spironolactone have a dose-dependent effect on left ventricular remodeling in patients with preserved left ventricular function after an acute myocardial infarction?
    Vatankulu MA; Bacaksiz A; Sonmez O; Alihanoglu Y; Koc F; Demir K; Gul EE; Turfan M; Tasal A; Kayrak M; Yazici M; Ozdemir K
    Cardiovasc Ther; 2013 Aug; 31(4):224-9. PubMed ID: 22963506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials.
    Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E
    G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of left ventricular changes after acute myocardial infarction using transthoracic real-time three-dimensional echocardiography.
    Yang NI; Hung MJ; Cherng WJ; Wang CH; Cheng CW; Kuo LT
    Angiology; 2008 Dec-2009 Jan; 59(6):688-94. PubMed ID: 18445615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study.
    Rauch B; Schiele R; Schneider S; Gohlke H; Diller F; Gottwik M; Steinbeck G; Heer T; Katus H; Zimmer R; Erdogan A; Pfafferott C; Senges J;
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):365-75. PubMed ID: 17124558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter by Nägele Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Nägele MP
    Circulation; 2017 Jan; 135(2):e11-e12. PubMed ID: 28069717
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter by Koh Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Koh KK
    Circulation; 2017 Jan; 135(2):e9-e10. PubMed ID: 28069716
    [No Abstract]   [Full Text] [Related]  

  • 17. Response by Heydari et al to Letter Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Heydari B; Harris WS; Kwong RY
    Circulation; 2017 Jan; 135(2):e13-e14. PubMed ID: 28069718
    [No Abstract]   [Full Text] [Related]  

  • 18. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
    Rauch B; Schiele R; Schneider S; Diller F; Victor N; Gohlke H; Gottwik M; Steinbeck G; Del Castillo U; Sack R; Worth H; Katus H; Spitzer W; Sabin G; Senges J;
    Circulation; 2010 Nov; 122(21):2152-9. PubMed ID: 21060071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.